EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Tenascin-C Potentiates Wnt Signaling in Thyroid Cancer

Heather A Hartmann iD, Matthew A Loberg, George J Xu, Anna C Schwarzkopf, Sheau-Chiann Chen, Courtney J Phifer, Kailey Caroland, Hua-Chang Chen, Diana Diaz, Megan L Tigue, Amanda B Hesterberg, Jean-Nicolas Gallant und 14 weitere

Endocrinology · 2025

DOI: 10.1210/endocr/bqaf030 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Endocrinology, 2025. Verfasst von Heather A Hartmann und 25 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology, Microbiology, and Immunology, Vanderbilt University Medical Center, Nashville, TN 37232, USA. Hauptthemen laut MEDLINE: Tenascin, Thyroid Neoplasms, Wnt Signaling Pathway, Thyroid Carcinoma, Anaplastic. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 68 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NCI NIH HHS, NIGMS NIH HHS, NIEHS NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Tenascin-C (TNC) is a secreted extracellular matrix protein that is highly expressed during embryonic development and re-expressed during wound healing, inflammation, and neoplasia. Studies in developmental models suggest that TNC may regulate the Wnt signaling pathway. Our laboratory has shown high levels of Wnt signaling and TNC expression in anaplastic thyroid cancer (ATC), a highly lethal cancer with an abysmal approximately 3- to 5-month median survival. Here, we investigated the role of TNC in facilitating ligand-dependent Wnt signaling in thyroid cancer. We used bulk RNA-sequencing from 3 independent multi-institutional thyroid cancer patient cohorts. TNC expression was spatially localized in patient tumors with RNA in situ hybridization. The role of TNC was investigated in vitro using Wnt reporter assays and in vivo with a NOD.PrkdcscidIl2rg–/− mouse ATC xenograft tumor model. TNC expression was associated with aggressive thyroid cancer behavior, including anaplastic histology, extrathyroidal extension, and metastasis. Spatial localization of TNC in patient tissue demonstrated a dramatic increase in expression within cancer cells along the invasive edge, adjacent to Wnt ligand–producing fibroblasts. TNC expression was also increased in areas of intravascular invasion. In vitro, TNC bound Wnt ligands and potentiated Wnt signaling. Finally, in an ATC mouse model, TNC increased Wnt signaling, tumor burden, invasion, and metastasis. Altogether, TNC potentiated ligand-driven Wnt signaling and promotes cancer cell invasion and metastasis in a mouse model of thyroid cancer. Understanding the role of TNC and its interaction with Wnt ligands could lead to the development of novel biomarkers and targeted therapeutics for thyroid cancer.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

TenascinThyroid NeoplasmsWnt Signaling PathwayThyroid Carcinoma, AnaplasticAnimalsHumansMiceCell Line, TumorGene Expression Regulation, NeoplasticFemaleMice, Inbred NOD

Stichwörter der Autor:innen

Wnt-2invasionmetastasistenascin-cthyroid cancer

Substanzen

TenascinTNC protein, human

Autor:innen und Institutionen

  • Department of Pathology, Microbiology, and Immunology, Vanderbilt University Medical Center, Nashville, TN 37232, USA.
  • Department of Cell and Developmental Biology, Vanderbilt University, Nashville, TN 37232, USA.
  • Department of Biostatistics, Vanderbilt University Medical Center, Nashville, TN 37232, USA.
  • Department of Medicine, Vanderbilt University Medical Center, Nashville, TN 37232, USA.
  • Department of Otolaryngology-Head & Neck Surgery, Vanderbilt University Medical Center, Nashville, TN 37232, USA.
  • Department of Laboratory Medicine and Pathology, University of Washington School of Medicine, Seattle, WA 98195, USA.

ORCID-Profile: Heather A Hartmann, Quanhu Sheng, Vivian L Weiss

Förderung

  • NCI NIH HHS
  • NIGMS NIH HHS
  • NIEHS NIH HHS
  • NIH HHS
  • NIMH NIH HHS
  • NIH
  • NCI

Zitieren

APA

Hartmann, H. A., Loberg, M. A., Xu, G. J., Schwarzkopf, A. C., Chen, S. C., Phifer, C. J., Caroland, K., Chen, H. C., Diaz, D., Tigue, M. L., Hesterberg, A. B., Gallant, J. N., Shaddy, S. M., Sheng, Q., Netterville, J. L., Rohde, S. L., Solórzano, C. C., Bischoff, L. A., Baregamian, N., …, & Weiss, V. L. (2025). Tenascin-C Potentiates Wnt Signaling in Thyroid Cancer. Endocrinology. https://doi.org/10.1210/endocr/bqaf030

Vancouver

Hartmann HA, Loberg MA, Xu GJ, Schwarzkopf AC, Chen SC, Phifer CJ, et al. Tenascin-C Potentiates Wnt Signaling in Thyroid Cancer. Endocrinology. 2025. doi:10.1210/endocr/bqaf030

BibTeX
@article{Hartmann2025,
  author = {Hartmann, Heather A and Loberg, Matthew A and Xu, George J and Schwarzkopf, Anna C and Chen, Sheau-Chiann and Phifer, Courtney J and Caroland, Kailey and Chen, Hua-Chang and Diaz, Diana and Tigue, Megan L and Hesterberg, Amanda B and Gallant, Jean-Nicolas and Shaddy, Sophia M and Sheng, Quanhu and Netterville, James L and Rohde, Sarah L and Solórzano, Carmen C and Bischoff, Lindsay A and Baregamian, Naira and Hurley, Paula J and Murphy, Barbara A and Choe, Jennifer H and Huang, Eric C and Ye, Fei and Lee, Ethan and Weiss, Vivian L},
  title = {Tenascin-C Potentiates Wnt Signaling in Thyroid Cancer},
  journal = {Endocrinology},
  year = {2025},
  doi = {10.1210/endocr/bqaf030}
}
Kostenlos starten →